Tissue and stool microbiome in pediatric inflammatory bowel disease patients: diversity differs in patients with relapsing and non-relapsing Crohn’s disease
Tissue and fecal microbial markers can predict relapse in pCD patients with high prognostic power, providing a basis for precision medicine and personalized treatment strategies in pIBD.
Authors
- David Šmajs (ORCID: https://orcid.org/0000-0002-4176-3464)
- Tereza Pinkasová (ORCID: https://orcid.org/0000-0002-8834-5411)
- Matěj Hrala
- Juraj Bosák (ORCID: https://orcid.org/0000-0001-7136-8396)
- Petr Andrla
- Lenka Radová (ORCID: https://orcid.org/0000-0001-8103-148X)
- Leoš Křen (ORCID: https://orcid.org/0000-0002-9509-1552)
- Matěj Hrunka (ORCID: https://orcid.org/0000-0002-8154-1567)
- Tereza Deissová (ORCID: https://orcid.org/0000-0003-4853-1233)
- Júlia Bohošová (ORCID: https://orcid.org/0000-0003-1286-1118)
- Petr Jabandžiev (ORCID: https://orcid.org/0000-0002-4094-2364)
- Táňa Macháčková (ORCID: https://orcid.org/0000-0001-5055-7147)
- Martina Ambrozová
- Saša Zahornacká
Institutions
- Central European Institute of Technology (CZ)
- Masaryk University (CZ)
- Central European Institute of Technology – Masaryk University (CZ)
- University Hospital Brno (CZ)
Publication Details
- Journal
- Gut Pathogens
- Published
- 2025-11-15
- DOI
- https://doi.org/10.1186/s13099-025-00766-5
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission
- Ministerstvo Školství, Mládeže a Tělovýchovy
- Ministerstvo Zdravotnictví Ceské Republiky